Table 4 Proportion of cases with 4 points (indicating the need for molecular genetic testing), sensitivity, and specificity of Baser criteria for diagnosis of definite NF2 in the holdout subsets

From: Empirical development of improved diagnostic criteria for neurofibromatosis 2

Back to article page